How did FY26 performance compare to the prior period?

Performance was broadly flat. Revenue of ₹4,290 crore compares to an annualized ₹4,499 crore in the prior 9-month period, while profit of ₹856 crore is steady against an annualized ₹849 crore.

What dividend did the board declare?

The board recommended a final dividend of ₹60 per share.

Were there any major surprises in the financial results?

No. The filing is a routine annual report with no guidance changes, beats, or misses relative to market expectations.

Earnings · Household & Personal Products · Large cap

Procter & Gamble Hygiene and Health Care reports flat FY26 results

The FMCG firm posted revenue of ₹4,290 crore and a profit of ₹856 crore, maintaining performance levels consistent with the prior period.

— 1 earlier story on Procter & Gamble Hygiene and Health Care Ltd. →

PGHH 28 May 2026 · 1:51 PM IST Verify on BSE · NSE

Mkt cap₹32,834 cr

P/E38.20×

ROE86.38%

Debt / eq.0.00

Div yld1.73%

₹60 per share Final dividend recommended by the board for FY26.

What's new

FY26 revenue reached ₹4,290 crore.
Profit after tax for the year stood at ₹856 crore.
The board recommended a final dividend of ₹60 per share.

Why this matters

The results show a steady, flat performance for the company. There are no surprises here, as the figures align with previous periods and market expectations.

What we're watching

Any shifts in consumer demand patterns in the upcoming quarters.
The impact of input cost fluctuations on future margins.
Management commentary on volume growth targets.

The full read

Procter & Gamble Hygiene and Health Care closed FY26 with revenue of ₹4,290 crore and a profit after tax of ₹856 crore. These figures represent a flat performance when measured against the annualized ₹4,499 crore in revenue and ₹849 crore in profit recorded during the prior 9-month period. The board has recommended a final dividend of ₹60 per share. This is a routine annual disclosure. There are no surprises, guidance shifts, or profit warnings to report. The company continues its steady trajectory, and the numbers align with market expectations.

Questions answered

How did FY26 performance compare to the prior period?: Performance was broadly flat. Revenue of ₹4,290 crore compares to an annualized ₹4,499 crore in the prior 9-month period, while profit of ₹856 crore is steady against an annualized ₹849 crore.
What dividend did the board declare?: The board recommended a final dividend of ₹60 per share.
Were there any major surprises in the financial results?: No. The filing is a routine annual report with no guidance changes, beats, or misses relative to market expectations.

Mentioned: Procter & Gamble Hygiene and Health Care Ltd.

Primary source BSE · NSE

An independent reading of the company's own disclosure — the primary filing above is the final word.

Story so far

All notes on PGHH →

28 May 2026 · 1:51 PM IST Procter & Gamble Hygiene and Health Care reports flat FY26 results
today Procter & Gamble Hygiene and Health Care names Srividya Srinivasan CFO